Plasmid elimination and immunomodulation by 3-benzazepines in vitro

Area of Science:

• Medicinal Chemistry
• Immunology
• Microbiology

Background:

• 3-benzazepines are a class of compounds with diverse biological activities.
• Understanding their mechanisms of action is crucial for drug development.
• Assessing antimicrobial, plasmid curing, and ADCC effects provides insight into their therapeutic potential.

Purpose of the Study:

• To investigate the biological activities of various 3-benzazepine derivatives.
• To evaluate their antimicrobial, F'lac plasmid elimination, and antibody-dependent cellular cytotoxicity (ADCC) effects.
• To explore potential interactions and mechanisms underlying these activities.

Main Methods:

• Antimicrobial assays were performed.
• F'lac plasmid elimination activity (plasmid curing) was assessed at sub-inhibitory concentrations.
• Antibody-dependent cellular cytotoxicity (ADCC) assays using human leukocytes were conducted.
• Combinations of compounds (e.g., KF4 with verapamil or promethazine) were tested.

Main Results:

• A weak antiplasmid (plasmid curing) effect was observed for some compounds at sub-inhibitory concentrations.
• [KF4] inhibited the antiplasmid effect of promethazine, suggesting potential competition.
• Several 3-benzazepines (KF1, KF2, KF3, DA, NE) enhanced ADCC activity at 1.0 microgram/mL.
• Most tested 3-benzazepines were ineffective for plasmid curing but inhibited ADCC without a clear dose-dependent effect.

Conclusions:

• 3-benzazepines exhibit varied biological activities, including modulation of plasmid stability and immune cell function.
• Specific derivatives show potential for enhancing ADCC, while others may interfere with it.
• Further research is warranted to elucidate the precise mechanisms and therapeutic applications of these compounds.